NEW YORK (GenomeWeb News) – NanoInk today announced a $65 million financing led by Lurie Investments.
The Skokie, Ill., nanotechnology development and applications firm said in a statement that the money will be used to convert outstanding debt to equity and to expand its commercial activities. NanoInk markets and sells nine nanotechnology products across its different divisions.
The company has five divisions, including the Nano BioDiscovery division, created in 2008 to apply its technology to the life sciences market. The division supplies instruments, assay kits, and contract services for nanoscale protein detection using the company's Dip Pen Nanolithography nanofabrication technology.